Clinical Trials Using Siltuximab
Clinical trials are research studies that involve people. The clinical trials on this list are studying Siltuximab. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Siltuximab in Treating Patients with Multiple Myeloma or AL Amyloidosis Undergoing Donor Stem Cell Transplant
This phase II trial studies how well siltuximab works in treating patients with multiple myeloma or AL amyloidosis who are undergoing donor stem cell transplant. Monoclonal antibodies, such as siltuximab, may interfere with the ability of cancer cells to grow and spread.
Location: Memorial Sloan Kettering Cancer Center, New York, New York